Anti-CGRPs in Migraine Prevention

Introduction

Take This Event

This webcast aims to address the unmet needs of Migraine and what impacts patients the most while highlighting on the new CGRP Monoclonal Antibodies’ effectiveness to address the unmet needs that the health care provider face in their clinics

Objectives

Address the unmet need in prevention of Migraine and understand its impact on patients.
Understand the Real-World data on effectiveness, safety and tolerability of CGRPs in respect to the clinical trials.
Identify the appropriate patients for CGRP Monoclonal Antibodies.

See Registration Policies, Cancellations & Refunds